As of 2026-03-15, the Relative Valuation of IGM Biosciences Inc (IGMS) is (20.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.27 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1679.9%.
The range of the Relative Valuation is (18.99) - (20.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 25.6x | 23.4x |
| Forward P/E multiples | 21.6x - 23.0x | 22.3x |
| Fair Price | (18.99) - (20.22) | (20.07) |
| Upside | -1595.1% - -1692.0% | -1679.9% |
| Date | P/E |